Nasopharyngeal carcinoma in situ (NPCIS)—pathologic and clinical perspectives
暂无分享,去创建一个
Kwok Wai Lo | C. V. van Hasselt | J. Tong | K. Lo | Lisa Y. S. Chan | Y. Lo | Lisa Y S Chan | Charles Andrew van Hasselt | Martin Wai Pak | Ka Fai To | Y M Dennis Lo | J H M Tong | M. W. Pak | K. To | L. Chan | Lisa Y. S. Chan
[1] T. B. Teoh. Epidermoid carcinoma of the nasopharynx among Chinese : A study of 31 necropsies , 1957 .
[2] Li Pc,et al. The histopathologic classification, biologic characteristics and histogenesis of nasopharyngeal carcinomas. , 1962 .
[3] P. Liang,et al. The histopathologic classification, biologic characteristics and histogenesis of nasopharyngeal carcinomas. , 1962, Chinese medical journal.
[4] P. Liang. STUDIES ON NASOPHARYNGEAL CARCINOMA IN THE CHINESE. STATISTICAL AND LABORATORY INVESTIGATIONS. , 1964, Chinese medical journal.
[5] Li Pc. STUDIES ON NASOPHARYNGEAL CARCINOMA IN THE CHINESE. STATISTICAL AND LABORATORY INVESTIGATIONS. , 1964 .
[6] R. W. Mallen,et al. Nasopharyngeal carcinoma in Eskimos. , 1974, Canadian journal of otolaryngology.
[7] W. Henle,et al. Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma , 1976, International journal of cancer.
[8] A. Lanier. Survey of cancer incidence in Alaskan natives. , 1977, National Cancer Institute monograph.
[9] G. de‐Thé,et al. SERUM IgA ANTIBODIES TO EPSTEIN-BARR VIRUS CAPSID ANTIGEN PRECEDING SYMPTOMS OF NASOPHARYNGEAL CARCINOMA , 1978, The Lancet.
[10] T. Bender,et al. Epstein‐Barr virus‐specific antibody titers in seven Alaskan Natives before and after diagnosis of nasopharyngeal carcinoma , 1980, International journal of cancer.
[11] Y. Zong,et al. Histopathology of paracancerous nasopharyngeal carcinoma in situ. , 1986, Chinese medical journal.
[12] Zong Ys,et al. Histopathology of paracancerous nasopharyngeal carcinoma in situ. , 1986 .
[13] N. Raab-Traub,et al. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.
[14] U. Nater,et al. Epstein-Barr virus. , 1991, The Journal of family practice.
[15] S. Leung,et al. Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: incidence and determinants. , 1992, The British journal of radiology.
[16] Y. F. Poon,et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. , 1993, International journal of radiation oncology, biology, physics.
[17] Kathryn Flynn,et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. , 1995, The New England journal of medicine.
[18] A. Theamboonlers,et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] A. Lee,et al. Nasopharyngeal carcinoma in situ , 1998, Cancer.
[20] S. Leung,et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. , 1999, Cancer research.
[21] S. Leung,et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. , 1999, Cancer research.
[22] Jian-Min Yuan,et al. Epidemiology of nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.